Research Portfolio
We invite you to learn about the Foundation's research grants. The search feature and the table below represent the Foundation's complete research portfolio. You may search the complete list of grants by status (open/active or closed/inactive), research program area, and disease.
If you are interested in a specific research program area, browse the recently funded research by program area.
Filter for Grant pages
Keyword Search for Grant pages
Search Results
|
Title |
Institution |
Investigator |
Status |
Research Program Area |
| 03186-A: Comparison of Genomic Mutation Status Between Primary Site and Metastatic Lymph Node in Canine Oral Malignant Melanoma | University of Missouri | Yoshimi Iwaki, DVM | Open | Oncology |
| 03228: Identification of Tumor-Specific Proteins for Targeted Therapy in Solid and Disseminated Histiocytic Sarcoma | University of Zurich | Enni Markkanen, Dr. med. vet., Dr. sc. nat. | Open | Oncology |
| 3195: Early Genetic Markers of Histiocytic Sarcoma for Faster Diagnosis and More Effective Treatment | CNRS - University of Rennes | Benoit Hedan, DVM, PhD | Open | Oncology |
| 03121: Optimizing HITI CRISPR/Cas9 Gene Editing for Treating Defective Pyruvate Dehydrogenase Kinase 4 in Doberman Pinschers | University of Florida | Christopher J Martyniuk, PhD | Open | Cardiology |
| 03103: Identification of Genetic Mutations in AnalSac Carcinoma Development in English Cocker Spaniels, Part II – Validation | University of Georgia | Shaying Zhao, PhD | Open | Oncology |
| 03100-A: The Use of Artificial Intelligence and Computed Tomography Image Features to Predict Sentinel Lymph Node Metastasis in Dogs with Oral Tumours | Ontario Veterinary College | Christopher Pinard, DVM | Open | Oncology |
| 02992-A: Sentinel Lymph Node Mapping for Dogs with Lung Tumors | University of Guelph | Michelle Oblak, DVM, DVSc | Open | Oncology |
| 03017: Molecular Characterization of Canine Soft Tissue Sarcomas Using Spatially Defined Proteomics and Transcriptomics | University of Zurich | Enni Markkanen, Dr. med. vet., Dr. sc. nat. | Open | Oncology |
| 03009: Evaluating Accuracy for Identification of Sentinel Lymph Nodes in Dogs with Cutaneous MCT: A Comparison | University of Florida | Judith Bertran, DVM, MS and Natalie Worden, DVM | Open | Oncology |
| 03019: Evaluation of a Targeted Anti αvβ3 Integrin Near-InfraRed (NIR-) Dye for Controlled Resection of Naturally Occurring Soft Tissue Sarcomas in Dogs | University of Zurich | Mirja Nolff, Dr. med. vet., DVM | Open | Oncology - Osteosarcoma, Oncology |
| 02987: It’s All In The Genes: The Mutational Landscape of Acute Myeloid Leukemia in Dogs | Cornell University | Tracy Stokol, BVSc, PhD | Open | Blood Disorders, Oncology |
| 02907: Ultrasound-guided Histotripsy Ablation of Canine Brain Tumors through an Acoustically Transparent Cranial Window | Virginia-Maryland Regional College of Veterinary Medicine | John Rossmeisl, DVM, MS | Open | Oncology |
| 02880: Enhanced Surgical Margin Imaging with Polarization-sensitive Optical Coherence Tomography in Canine Soft Tissue Sarcoma and Mammary Tumors | The Ohio State University | Laura Selmic, BVetMed, MPH | Open | Oncology |
| 02858-A: Investigation of Mechanisms of Resistance to Immunotherapy in Dogs with Spontaneous High-grade Glioma | University of Minnesota | Susan Arnold, DVM | Closed | Oncology |
| 02879: Use of CRISPR-based Genome-wide Approach for Identification of Vulnerabilities in Canine Oral Melanoma | R(D)SVS and Roslin Institute, University of Edinburgh | Maciej Parys, DVM, PhD | Open | Oncology |
| 02910: Open-Label, Phase-2 Clinical Trial of Chlorambucil and Toceranib for Canine Mast Cell Tumors | Colorado State University | Kristen Weishaar, DVM, MS | Open | Oncology |
| 02920: Continued Investigation into Tumor-permissive Collagen Signatures in Canine Mammary Gland Tumors: Development of Prognostic Markers and Targeted Therapies for Improved Outcomes | University of Pennsylvania | Susan W. Volk, VMD, PhD | Open | Oncology |
| 02855-A: Repurposing Drugs to Modulate Myeloid-derived Suppressor Cells (MDSCs) in Canine Soft Tissue Sarcomas | Louisiana State University | Sita Withers, BVSc, PhD | Open | Oncology |
| 02759-T: Reprogramming the Tumor Immune Niche in Canine Hemangiosarcoma | University of Florida | Jong Hyuk Kim, DVM, PhD | Closed | Oncology - Hemangiosarcoma |
| 02758: Optical Coherence Tomography for Margin Evaluation of Canine Skin and Subcutaneous Neoplasms | The Ohio State University | Laura Selmic, BVetMed, MPH | Closed | Oncology |
| 02772: Identifying Early Stage Ultra-rare Mutations as Predictive Biomarkers of Lymphoma in High-risk versus Low-risk Breeds Within the Dog Aging Project | University of Washington | Daniel Promislow, PhD | Closed | Oncology - Lymphoma |
| 02773: Histotripsy for Treatment of Canine Appendicular Osteosarcoma | Virginia-Maryland Regional College of Veterinary Medicine | Joanne Tuohy, DVM, PhD | Closed | Oncology - Osteosarcoma |
| 02746-A: Evaluation of Serum miRNA as a Diagnostic Tool for Canine Splenic Hemangiosarcoma | University of Georgia | Janet Grimes, DVM, MS | Closed | Oncology - Hemangiosarcoma |
| 02780: Bladder Carcinogen Exposures in Pet Dogs | University of Wisconsin, Madison | Lauren Trepanier, DVM, PhD | Closed | Oncology |
| 02782: Genetic Contribution to Early-onset Osteosarcoma | University of Wisconsin, Madison | Susannah Sample, DVM, MS, PhD | Open | Oncology - Osteosarcoma |
| 02783: Transcriptional Profiling of Canine Soft Tissue Sarcoma | Cornell University | Andrew D. Miller, DVM | Closed | Oncology |
| 02739-A: The Role of the Putative Tumor Suppressor Gene SETD2 in Canine Diffuse Large B-cell Lymphoma | Michigan State University | Bonnie Harrington, DVM, PhD | Closed | Oncology - Lymphoma |
| 02751-A: Luteinizing Hormone Receptor Activation Induces Migration and Adhesion in Neoplastic Canine Lymphocytes | Oregon State University | Michelle Kutzler, DVM, PhD | Closed | Oncology - Lymphoma |
| 02732-A: Tumor-educated Platelets: A Novel Minimally Invasive Liquid Biopsy for Early Cancer Diagnosis | Texas A&M AgriLife Research | Blanca M. Lupiani, PhD | Open | Oncology |
| 02534: Clinical Trial for Evaluation of Propranolol and Doxorubicin in the Treatment of Canine Hemangiosarcoma | University of Minnesota | Erin B. Dickerson, PhD and Antonella Borgatti, DVM, MS | Open | Oncology - Hemangiosarcoma |
| 02643-A: Examination of the Effects of Cannabidiol on Canine Neoplastic Cell Apoptosis/Autophagy and Potential for Chemotherapy Resistance or Sensitivity | Cornell University | Joseph J. Wakshlag, DVM, PhD | Closed | Oncology |
| 02595-A: Defining the Flow Cytometric Characteristics of Normal and Diseased Canine Spleen and Visceral Lymph Nodes | University of Minnesota | Courtney E. Johnson, DVM | Closed | Oncology |
| 02642-A: NF-kappaB Inactivation Enhances Apoptosis in Canine Osteosarcoma Cells | University of Georgia | Travis Laver, VMD, PhD | Closed | Oncology - Osteosarcoma |
| 02663: Comparative Brain Tumor Consortium (CBTC) Meningioma Pathology Board | National Institutes of Health/National Cancer Institute/Center for Cancer Research/Comparative Oncology Program, Cornell University, and University of Pennsylvania | Amy LeBlanc, DVM, Andrew Miller, DVM and Molly Church, MS, VMD, PhD | Open | Oncology |
| 02636-A: Development of RNA in-situ Hybridization to Identify T Regulatory Cells and their Function within the Tumor Microenvironment of Canine Oral Malignant Melanoma | University of Florida | Sandra M. Bechtel, DVM | Closed | Oncology |
| 02487: OX40 Checkpoint Molecule Targeted Antibodies for Cancer Immunotherapy in Dogs | Colorado State University | Steven W. Dow, DVM, PhD | Closed | Oncology |
| 02522-A: The Investigation of Lypoxigenase-5 Expression in Canine Normal, Hyperplastic and Neoplastic Urinary Bladder Epithelium | University of Liverpool | Riccardo Finotello, DVM, PhD | Closed | Oncology |
| 02489: Tumor-permissive Collagen Signatures in Canine Mammary Gland Tumors: Development of Prognostic Markers and Targeted Therapies for Improved Outcomes | University of Pennsylvania | Susan W. Volk, VMD, PhD | Closed | Oncology |
| 02502: Precision Medicine for Canine Lymphoma | Trustees of the University of Pennsylvania | Nicola J Mason, BVetMed, PhD | Closed | Oncology - Lymphoma |
| 02510-T: Identification of Novel Synthetic Lethal Partners to Optimize PI3K Targeted Therapies in Canine Hemangiosarcoma | Tufts University School of Medicine | Cheryl A. London, DVM, PhD | Closed | Oncology - Hemangiosarcoma |
| 02500: Immune Targeting of the V600E B-Raf Neoantigen in Canine Urothelial Carcinoma | University of Pennsylvania | Nicola J Mason, BVetMed, PhD | Closed | Oncology |
| 02519: Prevalence of Bartonella spp. Infection in Dogs with Cardiac and Splenic Hemangiosarcomas within and between Geographic Locations | North Carolina State University | Edward B Breitschwerdt, DVM; Matthew Breen, PhD | Closed | Tick-Borne Disease Initiative , Oncology - Hemangiosarcoma |
| 02456-A: The Impact of Intravenous Anesthetic Agents on Canine Natural Killer Cell | Trustees of the University of Pennsylvania | Oliver A Garden, BVetMed, PhD | Closed | Oncology |
| 02455-A: Identification of genetic mutations in anal sac carcinoma in English Cocker Spaniels | University of Georgia | Shaying Zhao, PhD | Closed | Oncology |
| 02405-A: Transcriptome Based Diagnostics in Canine Soft Tissue Sarcoma | Cornell University | Andrew D. Miller, DVM | Closed | Oncology |
| 02321: Clinical Trial of Procaspase-3 Activator (PAC-1) in Combination with Hydroxyurea for Treatment of Canine Meningioma | University of Illinois | Timothy M. Fan, DVM, PhD | Closed | Oncology |
| 02318: Genetic and Environmental Risk for Lymphoma in Boxer Dogs | University of Wisconsin, Madison | Lauren A. Trepanier, DVM, PhD | Closed | Oncology - Lymphoma |
| 02316: Genetic Risk Factors for Canine T zone Lymphoma | Colorado State University | Anne A. Avery, DVM, PhD | Closed | Oncology - Lymphoma |
| 02317: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B cell Lymphoma | North Carolina State University | Matthew Breen, PhD | Closed | Oncology - Lymphoma |
| 02309-T: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma | University of Missouri | Angela McCleary-Wheeler, DVM, PhD | Closed | Oncology - Lymphoma |
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
